Codexis To Announce Fourth Quarter And Fiscal Year 2012 Financial Results On February 27, 2013
Codexis, Inc. (NASDAQ: CDXS), a developer of world-leading enzymes and processes for the production of pharmaceuticals, biofuels and bio-based chemicals, today announced it will host a live conference call and audio webcast on Wednesday, February 27, 2013 at 4:30 p.m. Eastern Time to discuss its fourth quarter and fiscal year 2012 financial results for the period ended December 31, 2012. The call and webcast will follow the release of fourth quarter and fiscal year financial results after market close. A recorded version of the call will be available approximately one hour after the call on the Investors section of the company's website, www.codexis.com, and will be archived for up to 30 days.
| What: | Codexis' Fourth Quarter and Fiscal Year 2012 Financial Results | |
| Date: | Wednesday, February 27, 2013 | |
| Time: | 4:30 p.m. ET | |
| Live Call: | US: 866-804-6924 | |
| International: 857-350-1670 | ||
| Passcode: 10379003 | ||
| Webcast: | www.codexis.com | |
| Replay: | US: 888-286-8010 | |
| International: 617-801-6888 | ||
| Passcode: 11023504 | ||
About Codexis, Inc.
Codexis, Inc. is a developer of world-leading enzymes and processes for
the production of pharmaceuticals, biofuels and bio-based chemicals.
Codexis' product lines include CodeXyme™ cellulase enzymes and CodeXol™
detergent alcohol. Partners and customers include global leaders such as
Merck, Pfizer and Arch Pharmalabs. For more information, see
www.codexis.com.
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
TheStreet Quant Ratings
TRY IT FREENew! $49.95/yr
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
Product Features:
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Dividend Stock Advisor
TRY IT FREEJim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
